Clinical trials
Pharmacogenomic Drug Interaction clinical trials
Below are recruiting pharmacogenomic drug interaction clinical trials, each written for real people, not researchers. We’re tracking 12 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06334315RecruitingPhase 4
Birth control pill study for healthy women
This study looks at how genes affect the way the body processes birth control pills. You take a low-dose pill for one cycle and have blood draws to measure hormone levels.
Aurora, ColoradoAges 18–45 - NCT05166694Recruiting
Personalized testing to check drug interactions and gene effects
This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.
Chicago, IllinoisAges 18 years+ - NCT06322238RecruitingPhase 2
Can a DNA test help prevent drug side effects in primary care?
This study tests whether a cheek-swab DNA test can help doctors choose safer medicines for you. If you are starting a new drug in primary care, you might join to help prevent side effects.
Rochester, MinnesotaAges 18 years+ - NCT06907784Recruiting
Genetic testing before certain meds in hospital or clinic
This trial checks if genetic testing can help doctors pick safer drugs for you when you are in the hospital or visiting a clinic. If you qualify, you will give a cheek swab and be followed for about 12 weeks.
ClydebankAges 18 years+ - NCT07216846Recruiting
Preventing medication harm in older adults after a fall
This trial tests a program for older adults (65+) who have had a fall at ground level. It aims to reduce harm from medications by using special care in the emergency department.
Delray Beach, FloridaAges 65–110 - NCT07100054Enrolling by invitation
Genetic markers for CDK4/6 inhibitor therapy in breast cancer
This trial looks at how genetic markers and other substances in your blood might help personalize treatment with CDK4/6 inhibitors, a targeted therapy for breast cancer. It aims to find better ways to predict which patients will benefit most.
London, OntarioAges 18 years+ - NCT06660264Enrolling by invitation
Pharmacist medication review with or without genetic testing
This trial tests whether a pharmacist review of your medications, plus information from a pharmacogenomic (PGx) test (which looks at how your genes affect your response to drugs), can help improve your medication plan. If you qualify, you'll get a free PGx test and a personalized medication review.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06448091Recruiting
Precision Medicine in the Emergency Room
This study tests whether using genetic information in the emergency department can help choose safer medications for patients 40 and older. It focuses on people who frequently visit the ER and are starting a new long-term medication.
Gainesville, FloridaAges 40 years+ - NCT06554288RecruitingPhase 1
Trihexyphenidyl for dystonia in cerebral palsy
This study tests how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy, a condition that causes muscle spasms. Researchers want to learn if a child’s genes affect how the medicine works and how the body processes it.
Kansas City, MissouriAges 5–17 - NCT05512169Recruiting
Genetic study in Indian children with newly diagnosed leukemia
This study looks at genetic (DNA) differences to understand acute lymphoblastic leukemia (ALL) in Indian children and how treatments may fit better. You may be able to join if your child is newly diagnosed, meets the study’s treatment plan rules, and provides consent.
New DelhiAges 1–18 - NCT06219720Recruiting
Study on how genes affect medication response
This study looks at how your genes affect the way your body handles medications. It aims to improve treatment by understanding genetic differences, especially if you take multiple medications.
Bryan, TexasAges 45 years+ - NCT06726590Recruiting
Gene testing for better medication outcomes
This study collects blood, urine, and cheek swabs, along with health information, to see how your genes affect your response to medications. You may be eligible if you take many medications or are on blood pressure or depression medication.
Bryan, TexasAges 18 years+
Hear when a new Pharmacogenomic Drug Interaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pharmacogenomic drug interaction?
- Yes. Clin2 currently lists 12 recruiting pharmacogenomic drug interaction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pharmacogenomic drug interaction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pharmacogenomic drug interaction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.